Gottardi, M.; Simonetti, G.; Sperotto, A.; Nappi, D.; Ghelli Luserna di Rorà , A.; Padella, A.; Norata, M.; Giannini, M.B.; Musuraca, G.; Lanza, F.;
et al. Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin. Cancers 2021, 13, 4566.
https://doi.org/10.3390/cancers13184566
AMA Style
Gottardi M, Simonetti G, Sperotto A, Nappi D, Ghelli Luserna di Rorà A, Padella A, Norata M, Giannini MB, Musuraca G, Lanza F,
et al. Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin. Cancers. 2021; 13(18):4566.
https://doi.org/10.3390/cancers13184566
Chicago/Turabian Style
Gottardi, Michele, Giorgia Simonetti, Alessandra Sperotto, Davide Nappi, Andrea Ghelli Luserna di Rorà , Antonella Padella, Marianna Norata, Maria Benedetta Giannini, Gerardo Musuraca, Francesco Lanza,
and et al. 2021. "Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin" Cancers 13, no. 18: 4566.
https://doi.org/10.3390/cancers13184566
APA Style
Gottardi, M., Simonetti, G., Sperotto, A., Nappi, D., Ghelli Luserna di Rorà , A., Padella, A., Norata, M., Giannini, M. B., Musuraca, G., Lanza, F., Cerchione, C., & Martinelli, G.
(2021). Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin. Cancers, 13(18), 4566.
https://doi.org/10.3390/cancers13184566
